CAJ | 학술논문

中西医结合治疗原发性肝癌在减少不良反应、提高患者的生存质量、延长生存期方面取得了一定成果，从手术切除、介入治疗、放化疗技术联合中医药治疗到基础的抗复发转移、促进肝癌细胞凋亡和增强西医疗效的机制均有大量文献报道，兹就临床与实验研究现状简要综述。
중서의결합치료원발성간암재감소불량반응、제고환자적생존질량、연장생존기방면취득료일정성과，종수술절제、개입치료、방화료기술연합중의약치료도기출적항복발전이、촉진간암세포조망화증강서의료효적궤제균유대량문헌보도，자취림상여실험연구현상간요종술。
Integrative Chinese and western medicine therapy exhibited their achievements in reducing adverse reactions, improving the quality of life and prolonging the survival of the primary liver cancer (PLC) patients, which are reflected in the results of surgery, interventional therapy, chemotherapy, radiotherapy, recurrence and metastasis, promoting the liver cell apoptosis, and enhancing the effect of western medicine therapy. This article mainly overviews the current situation of clinical and experimental researches.